News | April 19, 2023
Multiple sclerosis market to generate sales of $29.8 billion by 2030, forecasts GlobalData
Several late-stage pipeline products have the potential to address some of these unmet needs
Several late-stage pipeline products have the potential to address some of these unmet needs
NGS enables researchers to quickly sequence entire genomes and transcriptomes of organisms.
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
It provides doctors with three indicators: identification of the bone, confirmation of device insertion into the bone, and notification in case of perforation through the opposite end of the bone
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
China is among the top countries reporting a high number of diagnosed prevalent cases for gastric, breast, and bladder cancers among the 16 major markets
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
Subscribe To Our Newsletter & Stay Updated
